Vista Pharmaceuticals Ltd. - Company Profile

Q: Who are the current directors of Vista Pharmaceuticals Ltd.?

The current directors of Vista Pharmaceuticals Ltd. are Mallem Hanumantha Rao, Pavan Sathvik Gilaka, Divakar Reddy Yerrabommanahalli, Stanley Prabhakar Reddy, Umesh Virupakah Banakar, Divya Bhavani Chakravarthula, Dhananjaya Alli, Suneel Pachipala, Barkha Jain, Umakanth Katta, Murali Meraga.

It is a pharma public limited company based in Na, Telangana, India, established in 1991.

1991 Na, Telangana, India Active

Last Updated: December 23, 2025

Access Report

About Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd., a active public limited company, was established on 25 January 1991 in Na, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239TG1991PLC012264. Registered under ROC Roc Hyderabad. it is listed on BSE: 524711. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹12.31 Cr.

It upholds a compliant status. In 2023, it reported revenue of ₹1.29 Cr and a net worth of ₹36.54 Cr. Its leadership includes Mallem Hanumantha Rao (Director), Pavan Sathvik Gilaka (Whole-Time Director), Divakar Reddy Yerrabommanahalli (Director). Past directors included Narendra Gilaka, Venkateswara Rao Yeragudipati, Arjun Upadhyay. It holds ₹17.00 Cr open charges and ₹16.08 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot Nos.10 To 14 And 16 To 20, Apiic, Industrial Estate, Chityal, Gop, Alaipalli, Na, Telangana, 508254.

Company Details

CIN/LLPIN
L24239TG1991PLC012264
Registration Number
012264
Incorporation Date
25 January 1991
Authorized Capital
₹15.00 Cr
Paid-Up Capital
₹12.31 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed (BSE: 524711)
Company Status
Active

Key Metrics

Authorised Capital ₹ 15.00 Cr as on 23-12-2025
Paid Up Capital ₹ 12.31 Cr as on 23-12-2025
Company Age 35 Year, 18 Days
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 17.00 Cr as on 23-12-2025
Satisfied Charges ₹ 16.08 Cr as on 23-12-2025
Revenue Growth **** 130.09% (FY 2023)
Profit Growth **** -599.25% (FY 2023)
Ebitda **** -83.49% (FY 2023)
Net Worth 3.06% (FY 2023)
Total Assets **** 1.69% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Vista Pharmaceuticals Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Vista Pharmaceuticals Ltd.?

Current Directors

Name	Designation	Appointment Date	Status
Mallem Hanumantha Rao	Director	16 Sep 1993	Current
Pavan Sathvik Gilaka	Whole-Time Director	14 Oct 2022	Current
Divakar Reddy Yerrabommanahalli	Director	30 Sep 2019	Current
Stanley Prabhakar Reddy	Director	12 Aug 2016	Current
Umesh Virupakah Banakar	Director	24 Feb 2018	Current
Divya Bhavani Chakravarthula	Director	24 Feb 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	08 Sep 2022	Past
Pramod Abcsdd	Director	18 Aug 2011	Past
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Director	20 Oct 2022	Past
Pramod Abcsdd	Director	01 Apr 2021	Past
Pramod Abcsdd	Additional Director	29 Dec 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vista Pharmaceuticals.

Vista Pharmaceuticals Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 130.09% increase. The company also saw a substantial fall in profitability, with a 599.25% decrease in profit. The company's net worth moved up by a moderate rise of 3.06%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

130.09%

*******

Revenue from Operations

*******

154.36%

*******

Total Assets

*******

1.69%

*******

Profit or Loss

*******

-599.25%

*******

Net Worth

*******

3.06%

*******

EBITDA

*******

-83.49%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vista Pharmaceuticals?

In 2023, Vista Pharmaceuticals had a promoter holding of 34.73% and a public holding of 65.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹170,000,000.00

Satisfied Charges

₹160,750,000.00

Charges Breakdown by Lending Institutions

Vijaya Bank : 17.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
23 Feb 2017	Vijaya Bank	₹17.00 Cr	Open
25 Jun 2015	State Bank Of India	₹8.00 Cr	Satisfied
02 May 2014	Allahabad Bank	₹4.00 Cr	Satisfied
16 Oct 1995	State Bank Of Hyderabad	₹1.10 Cr	Satisfied
12 Sep 1994	State Bank Of Hyderabad	₹2.08 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vista Pharmaceuticals?

Unlock and access historical data on people associated with Vista Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Vista Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vista Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vista Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Progress on Vista Pharmaceuticals Ltd. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
30 Sep 2024
Director Appointment

Progress on Barkha Jain was appointed as a Company Secretary was appointed as a Company Secretary on 03 May 2024 & has been associated with this company since 1 year 9 months . was documented.
03 May 2024
Balance Sheet

Progress on Vista Pharmaceuticals Ltd. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
31 Mar 2024
Director Appointment

Progress on Pavan Sathvik Gilaka was appointed as a Whole-time director was appointed as a Whole-time director on 14 Oct 2022 & has been associated with this company since 3 years 4 months . was documented.
14 Oct 2022
Director Appointment

The activity Murali Meraga was appointed as a Managing Director was appointed as a Managing Director on 14 Oct 2022 & has been associated with this company since 3 years 4 months . was completed.
14 Oct 2022
Director Appointment

The activity Umakanth Katta was appointed as a Director was appointed as a Director on 13 Jul 2020 & has been associated with this company since 5 years 7 months . was completed.
13 Jul 2020

Explore recent activity and updates - View Recent Activity